121 related articles for article (PubMed ID: 25678551)
21. A
Dumanski JP; Rasi C; Björklund P; Davies H; Ali AS; Grönberg M; Welin S; Sorbye H; Grønbæk H; Cunningham JL; Forsberg LA; Lind L; Ingelsson E; Stålberg P; Hellman P; Tiensuu Janson E
Endocr Relat Cancer; 2017 Aug; 24(8):427-443. PubMed ID: 28634180
[TBL] [Abstract][Full Text] [Related]
22. Gastric cancer: new genetic developments.
Lynch HT; Grady W; Suriano G; Huntsman D
J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
[TBL] [Abstract][Full Text] [Related]
23. [Gastric neuroendocrine tumors: clinical, endoscopic presentation and alternatives of treatment].
Lazarte R; Poniachik J; Smok G; Contreras J; Gutiérrez L; Csendes A
Rev Med Chil; 2002 Sep; 130(9):985-92. PubMed ID: 12434645
[TBL] [Abstract][Full Text] [Related]
24. Review article: the investigation and management of gastric neuroendocrine tumours.
Basuroy R; Srirajaskanthan R; Prachalias A; Quaglia A; Ramage JK
Aliment Pharmacol Ther; 2014 May; 39(10):1071-84. PubMed ID: 24628514
[TBL] [Abstract][Full Text] [Related]
25. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
26. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.
Huntsman DG; Carneiro F; Lewis FR; MacLeod PM; Hayashi A; Monaghan KG; Maung R; Seruca R; Jackson CE; Caldas C
N Engl J Med; 2001 Jun; 344(25):1904-9. PubMed ID: 11419427
[TBL] [Abstract][Full Text] [Related]
27. Exome sequencing identifies a novel variant in ACTC1 associated with familial atrial septal defect.
Greenway SC; McLeod R; Hume S; Roslin NM; Alvarez N; Giuffre M; Zhan SH; Shen Y; Preuss C; Andelfinger G; ; Jones SJ; Gerull B
Can J Cardiol; 2014 Feb; 30(2):181-7. PubMed ID: 24461919
[TBL] [Abstract][Full Text] [Related]
28. Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines.
Boora GK; Kanwar R; Kulkarni AA; Pleticha J; Ames M; Schroth G; Beutler AS; Banck MS
Cancer Genet; 2015; 208(7-8):374-81. PubMed ID: 26087898
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of benign gastric polyps in a large pathology database.
Sonnenberg A; Genta RM
Dig Liver Dis; 2015 Feb; 47(2):164-9. PubMed ID: 25458775
[TBL] [Abstract][Full Text] [Related]
30. Duodenal gastrinoma with multiple gastric neuroendocrine tumors secondary to chronic Helicobacter pylori gastritis.
Grin A; Kim YI; Mustard R; Streutker CJ; Riddell RH
Am J Surg Pathol; 2012 Jun; 36(6):935-40. PubMed ID: 22588069
[TBL] [Abstract][Full Text] [Related]
31. Pathophysiology of the fundic enterochromaffin-like (ECL) cell and gastric carcinoid tumours.
Modlin IM; Lawton GP; Miu K; Kidd M; Luque EA; Sandor A; Tang LH
Ann R Coll Surg Engl; 1996 Mar; 78(2):133-8. PubMed ID: 8678447
[TBL] [Abstract][Full Text] [Related]
32. Gastric neuroendocrine tumors in a
Zhang HF; Zheng Y; Wen X; Zhao J; Li J
World J Gastrointest Oncol; 2023 Aug; 15(8):1497-1504. PubMed ID: 37663942
[TBL] [Abstract][Full Text] [Related]
33. Luminescent Immunoprecipitation System (LIPS) for Detection of Autoantibodies Against ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+-ATPase in Atrophic Body Gastritis Patients.
Lahner E; Brigatti C; Marzinotto I; Carabotti M; Scalese G; Davidson HW; Wenzlau JM; Bosi E; Piemonti L; Annibale B; Lampasona V
Clin Transl Gastroenterol; 2017 Jan; 8(1):e215. PubMed ID: 28102858
[TBL] [Abstract][Full Text] [Related]
34. A novel VCP mutation as the cause of atypical IBMPFD in a Chinese family.
Gu JM; Ke YH; Yue H; Liu YJ; Zhang Z; Zhang H; Hu WW; Wang C; He JW; Hu YQ; Li M; Fu WZ; Zhang ZL
Bone; 2013 Jan; 52(1):9-16. PubMed ID: 23000505
[TBL] [Abstract][Full Text] [Related]
35. Exome sequencing in one family with gastric- and rectal cancer.
Thutkawkorapin J; Picelli S; Kontham V; Liu T; Nilsson D; Lindblom A
BMC Genet; 2016 Feb; 17():41. PubMed ID: 26872740
[TBL] [Abstract][Full Text] [Related]
36. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
[TBL] [Abstract][Full Text] [Related]
37. Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene.
More H; Humar B; Weber W; Ward R; Christian A; Lintott C; Graziano F; Ruzzo AM; Acosta E; Boman B; Harlan M; Ferreira P; Seruca R; Suriano G; Guilford P
Hum Mutat; 2007 Feb; 28(2):203. PubMed ID: 17221870
[TBL] [Abstract][Full Text] [Related]
38. [Basic and translational research progress of gastrointestinal neuroendocrine neoplasmas].
Song Y; Li X; Song T; Lin G; Chen Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1217-1221. PubMed ID: 27928788
[TBL] [Abstract][Full Text] [Related]
39. Gastric carcinoids after long-term use of a proton pump inhibitor.
Jianu CS; Fossmark R; Viset T; Qvigstad G; Sørdal O; Mårvik R; Waldum HL
Aliment Pharmacol Ther; 2012 Oct; 36(7):644-9. PubMed ID: 22861200
[TBL] [Abstract][Full Text] [Related]
40. [Gastric proton pump: genes and their expression].
Futai M
Nihon Rinsho; 1996 Apr; 54(4):1138-43. PubMed ID: 8920687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
